4.6 Article

Identification of a prognostic immune-related signature for small cell lung cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Harnessing Natural Killer Immunity in Metastatic SCLC

Sarah A. Best et al.

JOURNAL OF THORACIC ONCOLOGY (2020)

Article Immunology

A New Hope for CD56negCD16pos NK Cells as Unconventional Cytotoxic Mediators: An Adaptation to Chronic Diseases

Catherine S. Forconi et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Review Oncology

Targeted Therapies and Biomarkers in Small Cell Lung Cancer

Hirokazu Taniguchi et al.

FRONTIERS IN ONCOLOGY (2020)

Review Biotechnology & Applied Microbiology

Immunotherapy for small cell lung cancer: mechanisms of resistance

Gerhard Hamilton et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2019)

Article Oncology

Surgical Resection of SCLC: Prognostic Factors and the Tumor Microenvironment

Xiaoliang Zhao et al.

JOURNAL OF THORACIC ONCOLOGY (2019)

Article Multidisciplinary Sciences

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients

Xu-Chao Zhang et al.

NATURE COMMUNICATIONS (2019)

Letter Oncology

Immune Cell Infiltration Is a Strong Prognostic Indicator in Surgical Resection of SCLC

Ningning Zhou et al.

JOURNAL OF THORACIC ONCOLOGY (2019)

Review Oncology

The role of immunotherapy in small cell lung cancer

A. Calles et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2019)

Article Multidisciplinary Sciences

Circulating CD56bright NK cells inversely correlate with survival of melanoma patients

Kaat de Jonge et al.

SCIENTIFIC REPORTS (2019)

Review Oncology

Role of natural killer cells in lung cancer

Ozge Nur Aktas et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)

Article Biochemistry & Molecular Biology

Circadian regulator NR1D2 regulates glioblastoma cell proliferation and motility

Min Yu et al.

ONCOGENE (2018)

Review Oncology

Targeted Therapy and Immune Therapy for Small Cell Lung Cancer

Shirish M. Gadgeel

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)

Review Oncology

Unravelling the biology of SCLC: implications for therapy

Joshua K. Sabari et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Article Virology

Emerging Role of PML Nuclear Bodies in Innate Immune Signaling

Myriam Scherer et al.

JOURNAL OF VIROLOGY (2016)

Article Biotechnology & Applied Microbiology

Expression and clinicopathological implication of DcR3 in lung cancer tissues: a tissue microarray study with 365 cases

Yu Zhang et al.

ONCOTARGETS AND THERAPY (2016)

Article Oncology

Global Cancer Statistics, 2012

Lindsey A. Torre et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2015)

Article Multidisciplinary Sciences

Comprehensive genomic profiles of small cell lung cancer

Julie George et al.

NATURE (2015)

Review Pharmacology & Pharmacy

Sp1 transcription factor: A long-standing target in cancer chemotherapy

Carolina Vizcaino et al.

PHARMACOLOGY & THERAPEUTICS (2015)

Article Biochemical Research Methods

GSVA: gene set variation analysis for microarray and RNA-Seq data

Sonja Haenzelmann et al.

BMC BIOINFORMATICS (2013)

Editorial Material Oncology

Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis

Sana Intidhar Labidi-Galy et al.

ONCOIMMUNOLOGY (2012)

Review Pharmacology & Pharmacy

Targeting inflammation using selective glucocorticoid receptor modulators

Karolien De Bosscher et al.

CURRENT OPINION IN PHARMACOLOGY (2010)

Review Cell Biology

New insights into the robe of PML in tumour suppression

P. Salomoni et al.

CELL RESEARCH (2008)

Article Biochemistry & Molecular Biology

Plasmacytoid dendritic cells from human lung cancer draining lymph nodes induce Tc1 responses

Alexander Faith et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)

Review Immunology

The biology of human natural killer-cell subsets

MA Cooper et al.

TRENDS IN IMMUNOLOGY (2001)